Selected article for: "death cause and major cause"
Author: Merad, Miriam; Martin, Jerome C.
Title: Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
  • Cord-id: 3p2cuxk0
  • Document date: 2020_5_6
    • ID: 3p2cuxk0
    Snippet: The COVID-19 pandemic caused by infection with SARS-CoV-2 has led to more than 200,000 deaths worldwide. Several studies have now established that the hyperinflammatory response induced by SARS-CoV-2 is a major cause of disease severity and death in infected patients. Macrophages are a population of innate immune cells that sense and respond to microbial threats by producing inflammatory molecules that eliminate pathogens and promote tissue repair. However, a dysregulated macrophage response can
    Document: The COVID-19 pandemic caused by infection with SARS-CoV-2 has led to more than 200,000 deaths worldwide. Several studies have now established that the hyperinflammatory response induced by SARS-CoV-2 is a major cause of disease severity and death in infected patients. Macrophages are a population of innate immune cells that sense and respond to microbial threats by producing inflammatory molecules that eliminate pathogens and promote tissue repair. However, a dysregulated macrophage response can be damaging to the host, as is seen in the macrophage activation syndrome induced by severe infections, including in infections with the related virus SARS-CoV. Here we describe the potentially pathological roles of macrophages during SARS-CoV-2 infection and discuss ongoing and prospective therapeutic strategies to modulate macrophage activation in patients with COVID-19.

    Search related documents:
    Co phrase search for related documents
    • activation induce and acute inflammation: 1, 2, 3
    • activation recruitment and acute ali lung injury: 1, 2, 3, 4, 5
    • activation recruitment and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • activation recruitment and acute inflammation: 1, 2, 3
    • activation recruitment and adaptor molecule: 1, 2, 3
    • activation state and acute ards respiratory distress syndrome: 1, 2
    • activation state and acute inflammation: 1
    • activator transducer and acute ali lung injury: 1, 2, 3, 4, 5, 6
    • activator transducer and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5
    • activator transducer and acute inflammation: 1, 2, 3
    • activator transducer and additional pathway: 1
    • acute ali lung injury and additional insight: 1
    • acute ards respiratory distress syndrome and additional receptor: 1
    • acute inflammation and adaptor molecule: 1, 2